Computational exploration and design of a multi-epitopes vaccine construct against Chlamydia psittaci
Amal M Alsubaiyel1, Sarah I Bukhari2
1Department of Pharmaceutics, College of Pharmacy, Qassim University, Buraydah, Saudi Arabia.
Abstract:
Chlamydia psittaci is an intracellular pathogen and causes variety of deadly infections in humans. Antibiotics are effective against C. psittaci however high percentage of resistant strains have been reported in recent times. As there is no licensed vaccine, we used in-silico techniques to design a multi-epitopes vaccine against C. psittaci. Following a step-wise protocol, the proteome of available 26 strains was retrieved and filtered for subcellular localized proteins. Five proteins were selected (2 extracellular and 3 outer membrane) and were further analyzed for B-cell and T-cell epitopes prediction. Epitopes were further checked for antigenicity, solubility, stability, toxigenicity, allergenicity, and adhesive properties. Filtered epitopes were linked via linkers and the 3D structure of the designed vaccine construct was predicted. Binding of the designed vaccine with immune receptors: MHC-I, MHC-II, and TLR-4 was analyzed, which resulted in docking energy scores of -4.37 kcal/mol, -0.20 kcal/mol and -22.38 kcal/mol, respectively. Further, the docked complexes showed stable dynamics with a maximum value of vaccine-MHC-I complex (7.8 Å), vaccine-MHC-II complex (6.2 Å) and vaccine-TLR4 complex (5.2 Å). As per the results, the designed vaccine construct reported robust immune responses to protect the host against C. psittaci infections. In the study, the C. psittaci proteomes were considered in pan-genome analysis to extract core proteins. The pan-genome analysis was conducted using bacterial pan-genome analysis (BPGA) software. The core proteins were checked further for non-redundant proteins using a CD-Hit server. Surface localized proteins were investigated using PSORTb v 3.0. The surface proteins were BLASTp against Virulence Factor Data Base (VFDB) to predict virulent factors. Antigenicity prediction of the shortlisted proteins was further done using VAXIGEN v 2.0. The epitope mapping was done using the immune epitope database (IEDB). A multi-epitopes vaccine was built and a 3D structure was generated using 3Dprot online server. The docking analysis of the designed vaccine with immune receptors was carried out using PATCHDOCK. Molecular dynamics and post-simulation analyses were carried out using AMBER v20 to decipher the dynamics stability and intermolecular binding energies of the docked complexes.Communicated by Ramaswamy H. Sarma.
Insights
This study designed a multi-epitope vaccine against Chlamydia psittaci using in-silico methods due to rising antibiotic resistance. The computational approach predicted a robust vaccine construct with strong binding to immune receptors, indicating potential protection against C. psittaci infections.
Area of Science:
- Computational vaccinology
- Infectious disease research
- Bioinformatics
Background:
- Chlamydia psittaci is a dangerous intracellular pathogen causing severe human infections.
- Increasing antibiotic resistance in C. psittaci strains necessitates alternative control strategies.
- There is currently no licensed vaccine available for C. psittaci.
Purpose of the Study:
- To design a multi-epitope vaccine against Chlamydia psittaci using in-silico techniques.
- To evaluate the potential immunogenicity and stability of the designed vaccine construct.
Main Methods:
- Pan-genome analysis of 26 C. psittaci strains to identify core proteins.
- Prediction and filtering of B-cell and T-cell epitopes based on antigenicity, solubility, and stability.
- In-silico construction of a multi-epitope vaccine, 3D structure prediction, and docking analysis with MHC-I, MHC-II, and TLR-4 receptors.
Main Results:
- Selected extracellular and outer membrane proteins were analyzed for epitope prediction.
- The designed vaccine construct exhibited favorable antigenicity, stability, and adhesive properties.
- Docking analysis showed strong binding affinity to MHC-I (-4.37 kcal/mol), MHC-II (-0.20 kcal/mol), and TLR-4 (-22.38 kcal/mol), with stable complex dynamics.
Conclusions:
- The in-silico designed multi-epitope vaccine construct demonstrates potential for robust immune responses.
- The computational approach provides a promising strategy for developing a protective vaccine against Chlamydia psittaci infections.
More Related Videos
13:53Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
00:10Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
